" class="no-js "lang="en-US"> Appointments Archives - Page 17 of 45 - Medtech Alert
Sunday, October 12, 2025

Sort by:

Date

Top Post

Almirall Appoints Mercedes Diz as VP, Corporate Strategy

Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]

Annovis Bio Announces New Appointments to Strengthen Its Senior Leadership Team

Annovis Bio, a clinical-stage drug platform company addressing neurodegenerative diseases, has announced key additions to […]

Lyndra Therapeutics Announces New Board Members and Chief Technology Officer

Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced the appointment of […]

BICO Group Appoints Marius Balger as New COO

BICO Group is pleased to announce the appointment of Marius Balger as Chief Operating Officer […]

NHS England Appoints Leading Clinicians To Board

NHS England has added a wealth of clinical expertise and experience to its board with […]

CNS Pharmaceuticals Appoints Faith L. Charles, JD as Chair of the Board of Directors

CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]

NMD Pharma Appoints Mike Heffernan as Chairman of Board of Directors

NMD Pharma A/S, a clinical-stage biotech company developing first-in-class, small molecule ClC-1 inhibitors for neuromuscular […]

Vivera Welcomes CPG Leader Karen Antonio to its Advisory Board

Direct-to-consumer, consumer packaged goods (CPG), business development, and retail distribution expert Karen Antonio has joined Vivera […]

CN Bio Appoints Dr Paul Brooks as Chief Executive Officer

CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems […]

Eiger BioPharmaceuticals Announces Leadership Change

Eiger BioPharmaceuticals, a commercial-stage biopharmaceutical company focused on the development of innovative therapies for hepatitis […]

Almirall Appoints Mercedes Diz as VP, Corporate Strategy

Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more